Spyre Therapeutics, Inc. (SYRE)
33.56
-0.40
(-1.18%)
USD |
NASDAQ |
Feb 10, 16:00
33.59
+0.03
(+0.09%)
After-Hours: 20:00
Spyre Therapeutics EPS Diluted (Quarterly) : -0.184 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | 0.195 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.18M |
| Total Expenses (Quarterly) | 11.18M |
| Enterprise Value | 2.118B |
| Earnings Yield | -6.49% |
| Normalized Earnings Yield | -7.939 |